Meitav Dash Investments LTD Gamida Cell Ltd. Transaction History

Meitav Dash Investments LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$0.04 - $0.46 $16,704 - $192,105	-417,621 Reduced 11.43%	3,237,537 $129,000
Q3 2022 Oct 31, 2022	BUY	$1.53 - $3.39 $4.94 Million - $10.9 Million	3,225,806 Added 751.32%	3,655,158 $6.29 Million
Q3 2021 Nov 03, 2021	BUY	$3.85 - $6.44 $589,296 - $985,732	153,064 Added 55.4%	429,352 $1.68 Million
Q1 2021 May 06, 2021	BUY	$7.8 - $12.43 $2.06 Million - $3.28 Million	263,524 Added 2064.59%	276,288 $2.24 Million
Q4 2020 Feb 02, 2021	SELL	$4.07 - $11.0 $567,349 - $1.53 Million	-139,398 Reduced 91.61%	12,764 $106,000
Q3 2020 Nov 05, 2020	SELL	$3.93 - $4.59 $265,491 - $310,077	-67,555 Reduced 30.75%	152,162 $631,000
Q2 2020 Aug 10, 2020	BUY	$2.79 - $6.5 $613,010 - $1.43 Million	219,717 New	219,717 $1 Million
Q1 2020 May 11, 2020	SELL	$2.9 - $4.76 $648,779 - $1.06 Million	-223,717 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$4.01 - $5.25 $5,417 - $7,092	-1,351 Reduced 0.6%	223,717 $962,000
Q3 2019 Nov 14, 2019	BUY	$3.0 - $5.09 $15,000 - $25,450	5,000 Added 2.27%	225,068 $1.04 Million
Q2 2019 Aug 14, 2019	SELL	$4.98 - $11.32 $24,476 - $55,637	-4,915 Reduced 2.18%	220,068 $1.12 Million
Q1 2019 May 13, 2019	SELL	$9.8 - $14.38 $166 - $244	-17 Reduced 0.01%	224,983 $2.54 Million
Q4 2018 Feb 13, 2019	BUY	$8.44 - $15.41 $1.9 Million - $3.47 Million	225,000 New	225,000 $2.24 Million

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.